1. Buraggi G.L., 1985. Radioimmunodetection of cancer. J. Nucl. Med. Allied Sci. 29: 261.
2. Eger R.R., Covell D.G., Carrasquillo J.A., Abrams P.G., Foon K.A., Reynolds J.C., Schroff R.W., Morgan A.C., Larson S.M., Weinstein J.N.,. 1987. Kinetic model for the biodistribution of an 111In-labeled monoclonal antibody in humans. Cancer Res. 47: 3328.
3. Gobuty A.H., Kim E.E., Weiner R.E., 1985. Radiolabeled monoclonal antibodies: radiochemical pharmacoldnetic and clinical challenges. J. Nucl. Med. 26: 546.
4. Goodwin D.A., 1987. Pharmacokinetics and antibodies. J. Nucl. Med. 28: 1358.
5. Griffin T.W., Bokhari F., Collins J., Stochl M., Bernier M., Gionet M., Siebecker D., Wetheimer M., Giroves E.S., Grenfield L., Houston L.L., Doherty P.W., Wilson J., 1989. A preliminary pharmacokinetic study of 111In-labeled 260F9 anti-(breast cancer) antibody in patients. Cancer Immunol. Immunother. 29: 43.